• PUSAPATI SUCHITRA Department of Paediatrics, GITAM Institute of Medical Sciences and Research, GITAM Deemed to be University, Rushikonda, Visakhapatnam 530045, Andhra Pradesh, India
  • AMARTHYA SRV GITAM School of Sciences, GITAM Deemed to be University, Rushikonda, Visakhapatnam 530045, Andhra Pradesh, India
  • I. JYOTHI PADMAJA Department of Microbiology, GITAM Institute of Medical Sciences and Research, GITAM Deemed to be University, Rushikonda, Visakhapatnam 530045, Andhra Pradesh, India
  • PAYALA VIJAYALAKSHMI Department of Microbiology, GITAM Institute of Medical Sciences and Research, GITAM Deemed to be University, Rushikonda, Visakhapatnam 530045, Andhra Pradesh, India




Dengue, ELISA, Prevalence, Paediatric age group


Objective: The study's objective is to evaluate the prevalence of dengue in the paediatric age group based on demographic data and clinical symptoms.

Methods: The study was conducted in the Department of Paediatrics and Central Research Laboratory in a Tertiary Care Hospital in Visakhapatnam. Six months of data were collected from Jan 2022 to June 2022 and a maximum of 100 OPD/IPD cases have been registered during this study period. The entire medical history of all dengue cases, including signs and symptoms, method of diagnosis, management, length of stay, and clinical outcomes, were collected from patient information. NS1 antigen detection was performed by rapid test and Dengue ELISA was performed as a confirmatory test for the detection of IgG and IgM antibodies.

Results: Among the 100 suspected cases of dengue reported to OPD/IPD, 83(83%) were confirmed as dengue positive, and 17(17%) were found to be non-dengue cases with ELISA. More cases were noticed in female children 52 (55%). Prevalence was more in the age group of 5-11 y 43 (52%). The majority number of cases were reported with fever 82 (98.8%) followed by symptoms like vomiting 41(49%), cold 19(16%), and cough 18(15%).

Conclusion: Understanding dengue fever in children, including clinical symptoms, etiology, diagnostic testing, therapy, and prevention, is critical for lowering disease fatality rates.


Download data is not yet available.


Murugesan A, Manoharan M. Dengue virus. Emerg Reemerging Viral Pathog. 2020:281-359. doi: 10.1016/B978-0-12-819400-3.00016-8, PMCID PMC7149978.

Mutheneni SR, Morse AP, Caminade C, Upadhyayula SM. Dengue burden in India: recent trends and importance of climatic parameters. Emerg Microbes Infect. 2017;6(8):e70. doi: 10.1038/emi.2017.57, PMID 28790459, PMCID PMC5583666.

Witayathawornwong P. DHF in infants, late infants and older children: a comparative study. Southeast Asian J Trop Med Public Health. 2005;36(4):896-900. PMID 16295542.

Sim S, Hibberd ML. Genomic approaches for understanding dengue: insights from the virus, vector, and host. Genome Biol. 2016;17(17):38. doi: 10.1186/s13059-016-0907-2, PMID 26931545, PMCID PMC4774013.

Baak Baak CM, Cigarroa Toledo N, Pech May A, Cruz Escalona GA, Cetina Trejo RC, Tzuc Dzul JC. Entomological and virological surveillance for dengue virus in churches in Merida, Mexico. Rev Inst Med Trop Sao Paulo. 2019;61(61):e9. doi: 10.1590/S1678-9946201961009, PMID 30785563, PMCID PMC6376932.

Witayathawornwong P. Dengue hemorrhagic fever in infancy at Petchabun Hospital, Thailand. Southeast Asian J Trop Med Public Health. 2001;32(3):481-7. PMID 11944703.

Rahman M, Rahman K, Siddque AK, Shoma S, Kamal AH, Ali KS. First outbreak of dengue hemorrhagic fever Bangladesh. Emerg Infect Dis. 2002;8(7):738-40. doi: 10.3201/eid0807.010398, PMID 12095447.

Marra AR, de Matos GF, Janeri RD, Machado PS, Schvartsman C, Dos Santos OF. Managing patients with dengue fever during an epidemic: the importance of a hydration tent and of a multidisciplinary approach. BMC Res Notes. 2011;4:335. doi: 10.1186/1756-0500-4-335. PMID 21902823.

Rajapakse S, Rodrigo C, Rajapakse A. Treatment of dengue fever. Infect Drug Resist. 2012;5:103-12. doi: 10.2147/IDR.S22613. PMID 22870039, PMCID PMC3411372.

Rajapakse S. Dengue shock. J Emerg Trauma Shock. 2011;4(1):120-7. doi: 10.4103/0974-2700.76835, PMID 21633580, PMCID PMC3097561.

Padmanabhan PA, Ozhiparambil AJ, Padma U, Pragnatha K, Menon Veena P. A Retrospective study of paediatric dengue cases in a tertiary care Hospital in Southern India. J Clin Diagn Res. 2018;12(7):1-6.

Mital R, Agarwal V, Agarwal A. To assess the relative incidence of and to compare the hemocytological changes in malaria, dengue and typhoid fever or their combination in children admitted to a tertiary care centre in western UP, India. Int J Contemp Med Res. 2016;3(3):718-23.

Vazhayil PP, Stephen ST, Vinoth Kumar A. Retrospective observational study of dengue fever in a tertiary care center in Kerala. Int J Sci Study. 2017;5(1):31-4.

Padhi S, Dash M, Panda P, Parida B, Mohanty I, Sahu S. A three-year retrospective study on the increasing trend in seroprevalence of dengue infection from southern Odisha, India. Indian J Med Res. 2014;140(5):660-4. PMID 25579149.

Alok Kumar MK, Timmangouda RP, Santhosh V. Retrospective study of clinical profile and outcome of pediatric dengue cases in a Teaching hospital. Int J Contemp Pediatr. 2017;4(1):226-30.

Arun A, Prashant S, Aakanksha A, Gopesh T. Expanded dengue syndrome-A lesson learnt. Int J Trop Dis Health. 2017;28(4):1-8.

Khan MAS, Al Mosabbir A, Raheem E, Ahmed A, Rouf RR, Hasan M. Clinical spectrum and predictors of severity of dengue among children in 2019 outbreak: a multicenter hospital-based study in Bangladesh. BMC Pediatr. 2021;21(1):478. doi: 10.1186/s12887-021-02947-y, PMID 34715835.



How to Cite

SUCHITRA, P., A. SRV, I. J. PADMAJA, and P. VIJAYALAKSHMI. “POINT PREVALENCE OF PAEDIATRIC DENGUE VIRAL INFECTION”. International Journal of Current Pharmaceutical Research, vol. 15, no. 1, Jan. 2023, pp. 51-53, doi:10.22159/ijcpr.2023v15i1.2072.



Original Article(s)

Most read articles by the same author(s)